Oscar Health - Class A opened lower at $30.56, compared with its previous close of $30.79. In the last trading session, the stock traded between $29.94 and $30.87. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Oscar Health - Class A is now worth
$ 174.10
giving a profit of
$ 74.10 (74.10%)
Note: Past profits do not guarantee future returns.
Rating from 10 Analysts
Today's Change
$-0.71 (-2.29%)
Day High
$30.87
Day Low
$29.94
Day Open
$30.56
Prev Close
$30.79
Volume
13,10,789
1W Return
-9.70%
1M Return
1.08%
3M Return
-1.40%
6M Return
67.79%
1Y Return
59.10%
Market Cap ($ Mn)
8,227
PE Ratio
23.62
PB Ratio
4.58
PEG Ratio
-
ROE
-40.21%
ROCE
-
EPS (TTM)
$1.18
1 Week
-9.70%
1 Month
1.08%
3 Months
-1.40%
6 Months
67.79%
9 Months
101.51%
Oscar Health expands footprint to 21 states with new 2027 insurance plans
Oscar Health expands its footprint to 713 counties across 21 states, a 24% increase from last year. New RetireEase plan launched in five states to aid transition from early retirement to Medicare. HelloMeno program expanded to 15 states, offering $0 menopause-related care packages. Partnership with Allstate Health Solutions adds supplemental cash-pay options in Florida and Texas.
10 days agoThrive Capital distributes 6.3 million Oscar Health shares to partners
Thrive Capital distributed 6.3 million Oscar Health Class A shares to limited partners on September 18, 2026. The move returns capital after a 14-year holding period and is not a sale by Thrive or CEO Joshua Kushner. Affiliates retain 4.7 million Class A and 32.9 million Class B shares post-distribution. The group maintains approximately 67% of the combined voting power of Oscar Health's outstanding common stock.
1mo agoOscar Health raises FY26 earnings guidance by $100 million
Oscar Health raised FY26 earnings from operations guidance by $100 million to $600-$800 million. Medical loss ratio outlook tightened by 50 bps to 81.0%-82.0%. Barclays raised price target to $49; Baird and Stephens also hiked targets. Shares rose 2.38% to $33.11, approaching 52-week high of $34.47. Total revenue guidance reaffirmed at $18.7-$19.0 billion.
1mo agoStephens & Co. Reiterates Equal-Weight on Oscar Health at $34
Stephens & Co. maintains Equal-Weight rating on Oscar Health. Price target held steady at $34 per share. Analyst Raj Kumar issued the latest coverage update.
1mo agoOscar Health hits 52-week high on strong 2026 start
Oscar Health, Inc. shares rose to a 52-week high, extending an 80% year-to-date gain, after management reaffirmed 2026 guidance for revenue of $18.7 billion to $19 billion and operating earnings of $250 million to $450 million at the Goldman Sachs conference. CFO Scott Blackley cited favorable utilization trends and a $130 million positive variance in the final 2025 Wakely report. The rally follows a historic Q1 earnings report where the company swung to a $679 million profit, membership grew 56% to 3.17 million, and the medical loss ratio improved to 70.5%.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $410.91 | +0.94% | $3,68,830.76M | 25.27 | |
| $90.33 | +0.42% | $1,15,529.36M | 24.49 | |
| $422.02 | +1.84% | $91,179.95M | 17.46 | |
| $298.41 | +1.16% | $78,851.86M | 11.53 | |
| $415.80 | +1.17% | $50,034.33M | 36.44 | |
| $68.62 | +2.34% | $33,971.57M | - | |
| $198.95 | +0.43% | $10,385.19M | 2,222.22 | |
| $28.40 | +1.90% | $2,179.05M | 28.26 | |
| $4.58 | -4.38% | $1,994.32M | - | |
| $8.06 | -1.47% | $1,671.93M | 71.71 |
An investment of $100 made 5 years ago in Oscar Health - Class A is now worth
$ 174.10
giving a profit of
$ 74.10 (74.10%)
Note: Past profits do not guarantee future returns.
